Is Daxor Corporation overvalued?

Daxor Corporation (DXR) looks overvalued — trading about 59% above its fair value.

Overvalued

Price

$11.47

Fair value

$4.74

Current P/E

30.0

Normal P/E

12.4

Market cap

$67.0M

Dividend yield

0.0%

Return on equity

12.7%

Sector

Healthcare

Fair value compares DXR's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 9 Sep 2026.

Related stocks